Delivery Order SPE2DB24D2101-SPE2DB25FKPCL
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Nexletol 180 mg tablets in quantities of 30 units. This competitive, firm fixed-price delivery order carries a ceiling value of $1,269.01 and has an ultimate completion date of August 19, 2025. The contract involves no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Nexletol 180 mg tablets (30-unit packaging) valued at $1,389.23. This competitively awarded, firm fixed-price delivery order is non-set-aside and has a completion date of July 31, 2025. The award is issued to AmerisourceBergen Drug Corp's Corporate Office, with performance taking place at the company's Conshohocken, Pennsylvania headquarters, which serves as a major hub for...
- This is a $3,793.11 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NEXLETOL 180 MG TABLET, a medication, with a completion date of May 27, 2025. The contract is not set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract (SPE2DB22D3004|SPE2DB24FPZ07) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of Nexletol 180 mg tablets. The $1,017.34 award has an ultimate completion date of April 15, 2024 and does not utilize a set-aside designation. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00...
- The Defense Logistics Agency awarded a $1,250.17 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Nexletol 180 mg on August 8, 2025, with completion targeted for August 11, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is the contractor's...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,342.52, is for the supply of NEXLETOL 180 MG TABLET medical products. It is a firm fixed-price contract with a period of performance through November 7, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp holds a...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,196.33 Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide NEXLETOL 180 MG TABLET medical products. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which supplies a comprehensive range of pharmaceutical and medical supplies to support military healthcare programs globally. The contract...
- This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $3,017.67 and is for the supply of NEXLETOL 180 MG TABLET UU 30S, a pharmaceutical product. The contract is a firm fixed-price delivery order, with a period of performance through December 14, 2023. This contract is not designated as a set-aside and was awarded through open competition. Amerisourcebergen Drug Corp is a...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,736.73 award is for the supply of NEXLETOL 180 MG Tablets and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,383.52, is for the delivery of the pharmaceutical product NEXLETOL 180 MG TABLET UU 30S. The contract has an ultimate completion date of April 8, 2025 and is a Firm Fixed Price Delivery Order. There is no set-aside designation for this award. AmerisourceBergen holds a significant Indefinite...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKPCLDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Nexletol 180 mg tablets (30-count units) on September 2, 2025, with a ceiling value of $2,667.56 and an ultimate completion date of September 3, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performs this work at its corporate office location in Conshohocken, PA. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally, including services to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. Nexletol is a prescription medication used in cardiovascular disease management, and this order fulfills specific medical supply requirements within the broader framework of the DLA's pharmaceutical prime vendor program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 9/2/25 |